Back
Xencor Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
27
XNCR
Xencor
Last Price:
20.27
Seasonality Move:
15.94%
Sell
11
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-10.02%
Sell
27
Xencor (XNCR)
is a Sell
Is Xencor a Buy, Sell or Hold?
- The current Xencor [XNCR] share price is $19.23. The Score for XNCR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- XNCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
XNCR Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
XNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.93 | Sell |
| Relative Strength Index (14 RSI): | 39.47 | Sell |
| Chaikin Money Flow: | 137536 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.19 - 22.07) | Sell |
| Bollinger Bands (100): | (19.27 - 22.87) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 29.5 | Sell |
| Chaikin Money Flow: | 117969 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.12) | Sell |
| Bollinger Bands (100): | (0.1 - 0.22) | Sell |
XNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.77 | Buy |
| 20-day SMA: | 20.22 | Sell |
| 50-day SMA: | 22.01 | Sell |
| 200-day SMA: | 20.94 | Sell |
| 8-day EMA: | 19.07 | Buy |
| 20-day EMA: | 19.99 | Sell |
| 50-day EMA: | 20.89 | Sell |
| 200-day EMA: | 21.86 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Sell |
| 20-day SMA: | 0.09 | Sell |
| 50-day SMA: | 0.12 | Sell |
| 200-day SMA: | 0.34 | Sell |
| 8-day EMA: | 0.08 | Sell |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.12 | Sell |
| 200-day EMA: | 0.57 | Sell |
Xencor Earnings Growth & XNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.01 per share, a decrease this year of $1.02 per share, and an increase next year of $0.51 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Xencor Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||